Fachkompetenz in Pharma und Dermatologie
Eurofins C&PC supports pharma-dermato
Entwicklung klinischer Studien
Projektleitung klinischer Studien
Kontinuierliche Überwachung und ärztliche Aufsicht
Datenbearbeitung und medizinische Dokumentation
Qualitätssicherung
Durchführung von Audits, Erstellung und Pflege von SOPs sowie Sicherstellung der Konformität mit den Standards GCP und ISO 14155:2020.
Ensuring the safety, efficacy, and regulatory compliance of pharma-dermato products requires deep scientific expertise and a robust clinical infrastructure.
Eurofins C&PC offers comprehensive dermatology-focused services that support the development of products addressing psoriasis, atopic dermatitis, alopecia, rare skin diseases, as well as aesthetic products and medical devices. Our capabilities span strategic and regulatory consulting, early-phase human safety and Proof-of-Concept studies, vasoconstrictor assays for topical corticosteroids, and global Phase II-IV clinical trials for new chemical entities, reformulations with known actives, and generics.
By combining scientific excellence with operational precision, we help you navigate the complexities of dermatological product development and bring safe, effective, and compliant solutions to market.
What sets Eurofins C&PC apart?
Targeted expertise in dermatology and pharma-dermato
Eurofins provides strategic and regulatory consulting for dermatological products, including those addressing psoriasis, atopic dermatitis, alopecia, and rare skin diseases, as well as aesthetic products and medical devices.
Comprehensive clinical capabilities
From early-phase human safety and Proof-of-Concept studies to vasoconstrictor assays and global Phase II-IV trials, our services support the full development lifecycle of new chemical entities, reformulations, and generics.
Integrated, quality-driven approach
With robust clinical project management, medical monitoring, data operations, and quality assurance under GCP and ISO 14155:2020 standards, we ensure your products meet the highest regulatory and scientific expectations.
